Cargando…
Corrigendum: Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast cancer cells and osteoclasts
Autores principales: | Feng, Ming-Xuan, Hong, Jian-Xin, Wang, Qiang, Fan, Yong-Yong, Yuan, Chi-Ting, Lei, Xin-Huan, Zhu, Min, Qin, An, Chen, Hai-Xiao, Hong, Dun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757193/ https://www.ncbi.nlm.nih.gov/pubmed/29308788 http://dx.doi.org/10.1038/srep46935 |
Ejemplares similares
-
Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts
por: Feng, Ming-Xuan, et al.
Publicado: (2016) -
Corrigendum: BCIP: A gene-centered platform for identifying potential regulatory genes in breast cancer
por: Wu, Jiaqi, et al.
Publicado: (2017) -
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
por: Huang, Kuan-lin, et al.
Publicado: (2017) -
Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells
por: Wang, Qiang, et al.
Publicado: (2018) -
Corrigendum: Bub1 is required for maintaining cancer stem cells in breast cancer cell lines
por: Han, Jeong Yoon, et al.
Publicado: (2016)